Chainreactor combines the power of 3D printing technology and machine learning to revolutionize the biotech industry. ChainReactor combines the power of 3D printing technology and machine learning to revolutionize the biotech industry. By making cutting-edge bioreactors scalable, we're paving the way for breakthroughs for the climate. Biotech, Deep Tech, and Additive Manufacturing

10 similar entities Type: Startup Activities: deeptech Technologies: A.I.

Technology-driven biotech with an AI-powered miniprotein RnD platform VRG Tx is technology-driven biotech with a drug discovery platform that integrates AI with wet lab processes to develop next-generation therapeutics. Our vision is to cure diseases through previously undruggable targets and inaccessible mechanisms of action. medicinal biotechnology, research, immunology autoimmune deases , translational health research, use of genetic engineering in medicine, anti cancer drug discovery, oncological drugs, autoimmune diseases, translational research, peptide, cellandgenetherapy, and genetherapy

164 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The network of bioproduction biotherapies integrators (RIBB) aims to coordinate, lead and assist the 8 integrators in the field of biotherapies and bioproduction, labeled as part of the “biotherapies and bioproduction of innovative therapies” (SABB) acceleration strategy so that they can respond to their technological platform missions on behalf of academic or industrial partners, and facilitate the industrialization of their technologies/products. Biotherapies, Bioproduction, Cell Therapy, Gene Therapy, and Extracellular Vesicles

88 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Pioneering Antibody Innovations to Defeat Cancer At VERAXA Biotech (NASDAQ:VRXA), we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including antibody-drug conjugates (ADCs), bispecific T cell engagers (BiTAC TCEs), and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA Biotech was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technologies. Cancer Research, Drug Development, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Next-Generation Synthetic Macrocycle Drug Discovery Our mission is to unlock drug discovery for challenging and currently undruggable pharmaceutical targets, which leave many diseases without effective treatments. The Pure-DEL platform enables, for the first time, the evaluation of billions of synthetic macrocycles with drug-like properties in a single experiment, with the goal of unlocking new disease targets and enabling orally available medicines. * Pure-DEL Technology: https://doi.org/10.1126/science.adn3412 * ETH News Article: https://ethz.ch/en/news-and-events/eth-news/news/2024/09/new-pharmaceutically-active-substances-from-billions-of-newly-combined-molecules.html * Drug Target Review: https://www.drugtargetreview.com/article/153843/unlocking-a-new-molecular-space-in-rapid-drug-discovery/ Drug discovery, DNA-Encoded Libraries, Macrocycles, 'Undruggable' Targets, Oral drug discovery, and Intracellular Targets

58 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing

336 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library

368 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Creating Tomorrow's Immunotherapies NXI therapeutics focuses on the research and development of a new generation of selective immunosuppressive drugs for autoimmune diseases and transplantations - with objectives of high efficacy, good safety without adverse effects as seen with conventional immunosuppressants.

220 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Exploiting a proprietary tech platform to develop biomolecular tools for therapeutic & synthetic biology applications PartitionBioTM Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications.

99 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Predicting life-changing drugs for patients with cancer Calico Biosystems is on a mission to help pharma companies create effective, affordable drugs faster to counter cancer multi-omics assay, computational modeling, drug efficacy prediction, combination therapy, and Cell and virus-based therapeutics' efficacy

587 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unlocking the therapeutic potential of protein stabilisation Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.

183 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Distribution of medical devices including superpulsed therapy lasers and PEMF therapy instruments Superpulsed therapeutic lasers: Lumix 2 Series, Superpulsed + CW therapeutic lasers: Lumix 3 Series, Superpulsed + CW therapeutic lasers: Lumix 4 Series, Lumix Lasers, superpulsed lasers, therapeutic lasers, medical devices, and technology

53 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Developing a new generation of vaccines and immunotherapeutic drugs Virometix is a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases

130 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based therapeutics using our proprietary OpTiMus® platform, based on a fully humanized TCR mouse that provides an almost unlimited source of unique, antigen-specific human TCRs. We combine world-leading expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. biotechnology, research, T cell, biologics, and science

63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing

468 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Health Research & Development Center BIONOVEO offers project leaders, whether they are industrial or academic, the skills and biological, technical and methodological resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes.

94 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Next Generation Drug Screening using Microfluidic Translational Models of Human Disease Accelerating drug candidate selection using human 3D models of disease at scale with microfluidic technology

92 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible.

297 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Innovative & green technology for the production of new 100% protein-based materials for biomedical applications Innovative & green technology for the production of new 100% protein-based materials for biomedical applications

51 similar entities Type: Startup Activities: biotech Technologies: New Materials

Patient-based drug discovery We design and apply unique patient-based cellular assays for large-scale phenotypic screening, leaning on the power of AI-driven image analysis. Integrated from bed to bench and back to bed, we aim to generate most efficient first-in-class therapeutic molecules for next generation medicine. AI image and data analysis, biology, high content screening, high throughput screening, deep learning, assay development, patient stratification, pyschiatric disorders, and cardiac muscle

260 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology

Previously impossible enzymes for your visionary products Biomatter is an enzyme design company creating previously impossible enzymes for health and sustainable manufacturing applications. We partner with leading companies across food, chemicals, home care, agriculture, diagnostics, and therapeutics to deliver new enzyme molecules — designed with AI and Physics, built and tested in our lab, in weeks rather than years. biocatalysis, enzyme design, enzyme optimization, enzyme discovery, enzyme engineering, biocatalysts, life sciences, api manufacturing, chemical manufacturing, synthetic biology, biomanufacturing, protein design, and protein engineering

74 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Speeding up the discovery of new drugs by combining continuous flow chemistry, automation and artificial intelligence At Fluidichem, we are revolutionising drug development with cutting-edge technology. Our innovative approach combines artificial intelligence (AI) with continuous flow chemistry to transform the synthesis of molecule libraries.

Type: Startup Activities: deeptech Technologies: A.I.

AI-native biotech building a Multimodal AI Platform for Modality Agnostic Drug DiscoveryTM We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

90 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Data Analytics Synthetic Biology

Engineering the future of aging medicine. We are advancing small molecule therapeutics for age-related diseases. Our platform enables precise, dynamic control of biological targets and pathways, generating high-fidelity datasets that, combined with advanced AI, unlock systematic exploration of previously inaccessible chemical space. At its core are our ultra-large, in-house aging datasets, which provide a rich foundation for target identification and therapeutic discovery. biotechnology, aging, drug discovery, machine learning, synthetic biology, optogenetics, artificial intelligence, rejuvenation, molecular biology, novel therapeutics, therapeutics, and small molecules

66 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning

Fast, integrated structural biology for drug discovery — MX, cryo-EM and biophysics. All our services include access to fully automated, remote-controlled protein-to-structure pipelines based on the innovative technologies CrystalDirectTM and CRIMS developed at EMBL.

60 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Reimagining known biology to deliver high impact medicines Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Pharmaceuticals, Liver Disease, Life Sciences, BioPharmaceuticals, CML, Oncology, and HemOnc

63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We turn medical devices into clinical reality neo-bionica bridges the gap between research and the clinic, providing world-class engineering expertise and links to leading clinicians to create life changing medical device solutions. Offering end-to-end medical device prototype development, from initial concept and rapid prototyping to pre-clinical testing and first-in-human prototypes for clinical trials

68 similar entities Type: Startup Activities: deeptech healthtech biotech manufacturing Technologies: Synthetic Biology

Advanced Biomaterials for Regenerative Medicine Tensive is a biomedical company developing advanced biomaterials for regenerative medicine applications, with a current focus on reconstructive surgery after breast cancer.

127 similar entities Type: Startup Activities: deeptech healthtech Technologies: New Materials Synthetic Biology

The ELEMENT Biotechnology is an innovative medical device health company focused on developing new solutions THE ELEMENT Biotechnology is a Medtech company based out of 9, Boulevard Gambetta, 38000, Grenoble, FRANCE Dispositifs médicaux, Biotechnologie, Medtech, Maladies neurodégénératives , Santé, Parkinson, and Innovation

143 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Disruptive Solutions, Healthier Futures FOSCA BioTech is developing disruptive technologies to simultaneously remove multiple cancer-related molecules, transforming cancer treatment approaches with unprecedented precision.

59 similar entities Type: Startup Activities: deeptech biotech

Nano Drug Solutions Revolutionizing neuropathy treatment Development of innovative nanomedicines targeting neuropathies, with a particular focus on hereditary neuropathies such as Charcot-Marie-Tooth disease Biothechnology

120 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Next-Generation Precision Medicine Approaches We combine cell reprogramming technology with artificial intelligence to detect precancerous signals for early diagnosis and to generate cohorts of patients for clinical trial in the dish and personalized therapy. Precision Medicine, Clinical Trial in the Dish, Personalized Care, Patient-derived models, Early Diagnosis, Solid Tumors, Cancer, Drug Screening, Pharmaco-Ethnicity, Artificial Intelligence, and Preclinical models

78 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology A.I.

Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

365 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

630 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Carvolix is a French medical technologies company, commercial and clinical stage, founded by Truffle Capital, that aims to become a global leader in the treatment of structural heart diseases and strokes, world's leading causes of mortality and disability. Carvolix develops novel AI and imaging driven mini-robots that make complex procedures doble by interventional cardiologists, as well as biomimetics heart valves.

25 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Modulating T-regulatory cells to balance immunity Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.

210 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

212 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We generate preclinical data that accelerates drug development. Modern research without blindspots, through a solution that unveils important insights in preclinical trials. Biotechnology , Drug development, Machine learning, Artificial Intelligence, Deep tech, Preclinical research, Animal welfare, and 3R

83 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

749 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing best-in-class NNMT inhibitors with a dual therapeutic effect to benefit patients with metabolic syndrome Cantoni Therapeutics is a biopharmaceutical spinout company from the University of Leiden (NL) developing best-in-class inhibitors of a single enzyme with a dual therapeutic effect to benefit patients with metabolic syndrome.

106 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Late clinical stage company focused on drug discovery and development for the treatments of rare disorders of the CNS For additional information: info@sombiotech.com Pre-clinical validation, Licensing, In silico screening, Rare Diseases, Drug repurposing, Orphan CNS indications, Central Nervous System, Intellectual Property, and Artificial Intelligence

96 similar entities Type: Startup Activities: biotech deeptech legaltech Technologies: A.I. Synthetic Biology

Creating a new path for neurodegenerative diseases Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition. alzheimer, terapia genica, gene therapy , disruptive therapy, Alzheimer´s Disease, Biomarker, neurodegenerative disease, neuroscience, neurociencia, enfermedades neurodegenerativas, neurodegeneration, dementia, and pioneering

68 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation.

485 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Proteins For Sustainability Cocoon Bioscience specializes in the manufacturing of high value enzymes using an automated platform leveraging cocooned insects as natural, low cost bioreactors.

190 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Glox Therapeutics Ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target Gram-negative Antimicrobial Resistant (AMR) pathogens.

86 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3D cell shape + AI to bring the right therapies to the right patients sooner Sentinal4D is an AI-powered cancer drug discovery and development company, with close ties to the Institute of Cancer Research. Sentinal4D represents a collaboration of physics, biology and artificial intelligence to drive novel cancer therapy candidates with a high probability of clinical success. Artificial Intelligence, Computer Vision, Systems Biology, and Drug Discovery

103 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Company specialized in developing new and advanced materials solutions for skin-interacting medical devices BestHealth4U is a company dedicated to the research and development of new and advanced material technologies for skin-interacting medical devices.

208 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Dairy Done Differently Imagindairy, a Foodtech company, is addressing the industry bottleneck by integrating deep tech with system biology to develop a commercial and viable animal free protein-based dairy product

92 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Artificial Intelligence Supported Design Patented Innovation 3D Corsets Artificial Intelligence Supported Design Patented Innovation 3D Corsets For Free Pre-Evaluation; +90 (542) 657 7406 3D-Printing, Digital Health, Patient-Fit, Digital Design, 3D Printing Technology, Artificial Intelligence Supported Design, Design Based on AI, Artificial Intelligence, Artificial Intelligence, Digital Health, Digital Design, and Personalized Design

57 similar entities Type: Startup Activities: healthtech deeptech Technologies: 3D Printing Synthetic Biology

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP

322 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Drug discovery with cutting-edge AI technology We’re pioneering the use of AI and shaping the future in drug discovery, significantly cutting costs and development times. Our unique AI algorithms have generated novel drug candidates and identified enhancements for existing therapies more efficiently than traditional methods, setting us apart in the competitive landscape. Artificial Intelligence, Data Science, Health, Medicines, and Drug development

152 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Genenta Science (Nasdaq: GNTA), which will be renamed as Saentra Forge (Nasdaq: SAEN) About: Genenta Science (Nasdaq: GNTA), which will be renamed as Saentra Forge (Nasdaq: SAEN, pending effectiveness), will be a next-generation strategic consolidator focused on privately held specialized companies operating in Italian national security regulated sectors, with activities spanning cybersecurity, defense, aerospace, and biotechnology/biosecurity. cell therapy, Defence, Cybersecurity, Aerospace, and National Security

64 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Peptide-based therapeutics for treating peripheral pain conditions At Akasi Pharma, we are developing novel peptide-based therapeutics to treat peripheral pain conditions Peptide therapeutics and Peripheral Neuropathic Pain

160 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Targeting CCN signaling to treat fibrosis Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

186 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advancing healthcare through innovative adenosine receptor-based drugs Palobiofarma S.L. is a Spanish biopharmaceutical company dedicated to discovering and developing innovative drugs based on the modulation of adenosine receptors.

256 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.

260 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Expanding the reach of highly potent cancer therapies with the pre|CISION® platform. Avacta is a clinical stage biotechnology company expanding the reach of highly potent cancer therapies with the pre|CISION® platform. Custom antibody alternative, Antibody alternatives, and Afinnity reagents

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

As one of core operating companies of the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of the health and well-being by linking pharmaceutical companies in Japan and overseas, leveraging its global network and expertise.

180 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology New Materials

Canton Strategic Holdings, Inc., is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Canton Strategic Holdings also operates clinical-stage biotech research and development. digital assets, biotech, and blockchain

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Curileum is intervening early in serious gastrointestinal (GI) disease development with novel diagnostics & therapeutics Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa Biotechnology

161 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances -

435 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Advancing the state-of-the-art in nature-based healthcare solutions Adamas Biotech exploits its core area of know-how, namely the anti-inflammatory, antioxidant and analgesic properties of green tea catechins to develop nutraceuticals and related products in the field of lower urinary tract symptoms and gastroenterology.

83 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

New therapeutic targets based on arsenic trioxide (As2O3) Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases. santé, biotechnologies, bioparma, biopharmaceutical, biotech, health, biotechnology, autoimmune diseases, and maladies auto-immunes

375 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Reversing Neurodegeneration - Restoring Life GeneCode is developing small-molecule drugs that bind and activate GDNF (Glial cell line-Derived Neurotrophic Factor) receptors for the treatment of Parkinson’s disease (PD) and other neurodegenerative conditions.

74 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Galactica Biotech applies AI methods to identify new applications for molecules, expanding the IP portfolio of companies in multiple areas. Molecule characterization, Novel compound applications, and Pesticides

95 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

InvenireX is democratizing detection of nucleic acid biomarkers InvenireX is developing real-time, ultra-sensitive Nucleic Acid detection instrumentation powered by the latest object-detection neural networks, to empower our Scientists to accelerate life-sciences research.

83 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work

128 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc...

422 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Uniqueness of Individualized Neoantigen Cancer Vaccine to Reshape the Future of Early-Stage Cancer Treatment Cancer immunotherapy Transgene (Euronext: TNG) is a clinical-stage biotechnology company focused on individualized therapeutic vaccines

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Making Regenerative Medicine Accessible Roumai Medical is developing next-generation biotechnologies in regenerative medicine and human-machine interface to meet the unmet clinical needs of millions of patients worldwide.

462 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Innovating with AI and nanotechnology to develop more effective health products in less time NanotheraTM is a startup that offers innovative solutions in R&D (Design/Nanoformulation) intended for parapharmaceutical and pharmaceutical laboratories. We combine AI and nanotechnology for more effective therapeutic solutions in less time. nanotechnology, Nutraceuticals, and Artificial Intelligence

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Addressing structural limitations beneath the skin Aliform is a VC-backed, clinical-stage medical device startup company developing new devices to make skin surgery safer, easier, and more accessible. Celluleaf®, our first product, is a minimally invasive tool designed to release fibrous septae under the skin while respecting surrounding tissue structures.

60 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Innovating Life Sciences InSilicoTrials is a leading technology company revolutionizing drug development through AI-powered simulation. Our platform provides pharmaceutical and biotech companies with access to a vast library of computational models, enabling them to simulate drug interactions, predict outcomes, and accelerate the discovery of new treatments. By leveraging digital patient twins and advanced AI algorithms, we offer a more efficient and cost-effective approach to drug development, reducing the need for early-stage human trials and improving decision-making throughout the process. in silico and drug development

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I.

The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design

86 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules

626 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Applying AI to drug discovery Evariste is an AI-enabled drug discovery company developing small molecule inhibitors of next generation synthetic lethality targets. Using our automated AI-enabled drug discovery platform, Frobenius, we are able to progress preclinical drug discovery projects at scale and with unparalleled efficiency. Technology , Software, Biotech, Research, and Drug Discovery

70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I.

Drugging disordered proteins with physics and AI Peptone is a therapeutics company that uses AI and an experimental physics product engine to design small molecules targeting the 6,200 intrinsically disordered human proteins that Alpha Fold 3 cannot model. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins

153 similar entities Type: Startup Activities: biotech deeptech it services Technologies: Synthetic Biology

A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation

584 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors.

164 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

MindMed is now Definium Therapeutics, a rebrand that reflects our commitment to forging a new era of psychiatry by applying precision to psychedelic medicine. Follow our new page at the link below!

55 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

702 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology